Angie Snell Bennett

Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant

Kirsten Schneider-Ohrum, Corinne Cayatte, Angie Snell Bennett et al. · Journal of Virology · 2017 · 71 citations · Full text

Functional Exhaustion of HBV-Specific CD8 T Cells Impedes PD-L1 Blockade Efficacy in Chronic HBV Infection

Sara Ferrando‐Martínez, Angie Snell Bennett, Elisabete Lino et al. · Frontiers in Immunology · 2021 · 31 citations · Full text

HBeAg seroconversion is associated with a more effective PD-L1 blockade during chronic hepatitis B infection

Sara Ferrando‐Martínez, Kelly Huang, Angie Snell Bennett et al. · JHEP Reports · 2019 · 30 citations · Full text

Feasibility of Freeze-Drying Oil-in-Water Emulsion Adjuvants and Subunit Proteins to Enable Single-Vial Vaccine Drug Products

Vidyashankara Iyer, Corinne Cayatte, Jason D. Marshall et al. · Journal of Pharmaceutical Sciences · 2017 · 28 citations

Vaccination, Medicine, Immunology +4

PCPP-Adjuvanted Respiratory Syncytial Virus (RSV) sF Subunit Vaccine: Self-Assembled Supramolecular Complexes Enable Enhanced Immunogenicity and Protection

Corinne Cayatte, Alexander Marin, Gaurav Manohar Rajani et al. · Molecular Pharmaceutics · 2017 · 24 citations

Vaccination, Rsv Sf, Vaccine Development +12